C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
C-C chemokine receptor type 4 (CCR4) is expressed on Th2 T lymphocytes and is up-regulated by T cell receptor activation. This receptor also plays an important role in the trafficking of dendritic cells.
The CCR4 pipeline market research report provides comprehensive information on the CCR4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, the latest news as well as press releases. Additionally, the report provides an overview of key players involved in C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) targeted therapeutics development with respective active and dormant or discontinued projects.
Key Therapy Areas in the CCR4 Pipeline Products Market
The key therapy areas in the CCR4 pipeline products market are oncology, dermatology, ear nose throat disorders, gastrointestinal, ophthalmology, and respiratory.
CCR4 Pipeline Products Market Analysis by Therapy Areas
For more therapy area insights, download a free report sample
Key Mechanisms of Action in the CCR4 Pipeline Products Market
The key mechanism of action in the CCR4 pipeline products market is C-C Chemokine Receptor Type 4 Antagonist.
Key Routes of Administration in the CCR4 Pipeline Products Market
The key routes of administration in the CCR4 pipeline products market are oral and intravenous.
CCR4 Pipeline Products Market Analysis by Routes of Administration
For more routes of administration insights, download a free report sample
Key Molecule Types in the CCR4 Pipeline Products Market
The key molecule types in the CCR4 pipeline products market are small molecule, peptide, gene-modified cell therapy, monoclonal antibody, and recombinant protein.
CCR4 Pipeline Products Market Analysis by Molecule Types
For more molecule type insights, download a free report sample
Major Companies in the CCR4 Pipeline Products Market
The major companies in the CCR4 pipeline products market are ChemoCentryx Inc, CohBar Inc, Eight Plus One Pharmaceutical Co Ltd, Lassogen Inc, RAPT Therapeutics Inc, and Tizona Therapeutics Inc.
CCR4 Pipeline Products Market Analysis by Companies
To know more about major companies, download a free report sample
CCR4 Pipeline Products Market Report Overview
Key Therapy Areas | Oncology, Dermatology, Ear Nose Throat Disorders, Gastrointestinal, Ophthalmology, and Respiratory |
Key Mechanisms of Action | C-C Chemokine Receptor Type 4 Antagonist |
Key Routes of Administration | Oral and Intravenous |
Key Molecule Type | Small Molecule, Peptide, Gene-Modified Cell Therapy, Monoclonal Antibody, and Recombinant Protein. |
Major Companies | ChemoCentryx Inc, CohBar Inc, Eight Plus One Pharmaceutical Co Ltd, Lassogen Inc, RAPT Therapeutics Inc, and Tizona Therapeutics Inc |
Scope
- The report provides a snapshot of the global therapeutic landscape for C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4)
- The report reviews C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing, and collaboration details & other developmental activities
- The report reviews key players involved in C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) targeted therapeutics and enlists all their major and minor projects
- The report assesses C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA), and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews the latest news and deals related to C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) targeted therapeutics
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage
- Identify and understand the targeted therapy areas and indications for C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and their most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding the C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
CohBar Inc
Eight Plus One Pharmaceutical Co Ltd
Lassogen Inc
RAPT Therapeutics Inc
Tizona Therapeutics Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key therapy areas in the CCR4 pipeline products market?
The key therapy areas in the CCR4 pipeline products market are oncology, dermatology, ear nose throat disorders, gastrointestinal, ophthalmology, and respiratory.
-
What are the key mechanisms of action in the CCR4 pipeline products market?
The key mechanism of action in the CCR4 pipeline products market is C-C Chemokine Receptor Type 4 Antagonist.
-
What are the key routes of administration in the CCR4 pipeline products market?
The key routes of administration in the CCR4 pipeline products market are oral and intravenous.
-
What are the key molecule types in the CCR4 pipeline products market?
The key molecule types in the CCR4 pipeline products market are small molecule, peptide, gene-modified cell therapy, monoclonal antibody, and recombinant protein.
-
Which are the major companies in the CCR4 pipeline products market?
The major companies in the CCR4 pipeline products market are ChemoCentryx Inc, CohBar Inc, Eight Plus One Pharmaceutical Co Ltd, Lassogen Inc, RAPT Therapeutics Inc, and Tizona Therapeutics Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.